News
Hosted on MSN1mon
FDA Gives A Green Light To Blujepa For Treating Uncomplicated UTIsOne of the most common adverse events that patients who have consumed Blujepa reported was gastrointestinal, including diarrhea, which was reported in 16% of the patients. Then came nausea at 9%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results